Anixa Biosciences, Inc. (ANIX) Ownership
ANIX ownership summary
as of October 17, 2026- Institutions
- 13.9% of shares outstanding
- Insiders
- 5.62% of shares outstanding
- Shares outstanding
- 34.8M
- Float
- 32.8M shares available to trade
- Short interest
- 4.10% 1.4M shares short
- Days to cover
- 3.58 short interest up 28.0% vs prior month
- Institutions 13.88%
- Insiders 5.62%
- Other investors 80.50%
ANIX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 3.83% | 1.3M | $3.6M | +14,870 (+1.1%) | June 30, 2026 |
| 2 | UBS Group AG | 1.68% | 585K | $1.6M | +33,793 (+6.1%) | June 30, 2026 |
| 3 | Laird Norton Tyee Trust Co | 1.66% | 579K | $1.5M | +12,400 (+2.2%) | June 30, 2026 |
| 4 | Davidson D A & Co | 1.55% | 539K | $1.4M | — | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 1.03% | 359K | $959,048 | −5,537 (−1.5%) | June 30, 2026 |
| 6 | Marshall Wace Asset Management Ltd | 0.94% | 328K | $876,646 | +155,153 (+89.6%) | June 30, 2026 |
| 7 | BlackRock Inc | 0.57% | 200K | $533,346 | +29,652 (+17.4%) | June 30, 2026 |
| 8 | Vanguard Fiduciary Trust Co | 0.55% | 192K | $513,591 | +1,282 (+0.7%) | June 30, 2026 |
| 9 | State Street Corp | 0.46% | 159K | $424,637 | — | June 30, 2026 |
| 10 | GSA Capital Partners LLP | 0.34% | 117K | $313,632 | +18,623 (+18.8%) | June 30, 2026 |
| 11 | LPL Financial Corp | 0.32% | 112K | $297,798 | +30,559 (+37.7%) | June 30, 2026 |
| 12 | Northern Trust Corp | 0.20% | 69K | $184,857 | +2,410 (+3.6%) | June 30, 2026 |
| 13 | Renaissance Technologies Corp | 0.17% | 59K | $158,526 | −1,800 (−2.9%) | June 30, 2026 |
| 14 | CoreCap Advisors, LLC | 0.15% | 52K | $138,893 | — | June 30, 2026 |
| 15 | Bank of New York Mellon Corp | 0.14% | 47K | $126,670 | — | June 30, 2026 |
| 16 | Westside Investment Management, Inc. | 0.12% | 43K | $114,810 | −4,000 (−8.5%) | June 30, 2026 |
| 17 | HighTower Advisors, LLC | 0.12% | 41K | $109,870 | −400 (−1.0%) | June 30, 2026 |
| 18 | Kestra Advisory Services, LLC | 0.11% | 38K | $101,460 | −13,000 (−25.5%) | June 30, 2026 |
| 19 | CI Private Wealth LLC | 0.11% | 37K | $99,858 | +17,400 (+87.0%) | June 30, 2026 |
| 20 | Gemmer Asset Management LLC | 0.10% | 35K | $93,450 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 316K shares and 5 cut 25K.
ANIX top mutual fund and ETF holders
11 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.70% | 937K | $2.5M | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.47% | 163K | $433,968 | −873 (−0.5%) | August 31, 2026 |
| 3 | iShares Micro-Cap ETF | 0.29% | 103K | $273,795 | −707 (−0.7%) | September 30, 2026 |
| 4 | Fidelity Total Market Index | 0.15% | 53K | $140,581 | — | August 31, 2026 |
| 5 | Fidelity Series Total Market Index | 0.13% | 47K | $124,542 | — | August 31, 2026 |
| 6 | Vanguard MStar Inst Ttl StkMktIdxInstlPl | 0.06% | 21K | $56,281 | — | August 31, 2026 |
| 7 | Vanguard Balanced Index Inv | 0.05% | 18K | $47,975 | — | August 31, 2026 |
| 8 | Schwab Total Stock Market Index | 0.04% | 13K | $34,136 | — | August 31, 2026 |
| 9 | Vanguard U.S. Eq Idx £ Acc | 0.03% | 11K | $28,646 | — | August 31, 2026 |
| 10 | 1290 VT Micro Cap K | 0.02% | 7,205 | $19,237 | — | August 31, 2026 |
| 11 | Fidelity Nasdaq Composite Index | 0.02% | 6,548 | $17,483 | −17,554 (−72.8%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ANIX insider transactions
latest 7| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-28 | Arnold M Baskies | Buy | $3.04 | 10,000 | $30,400 |
| 2025-07-31 | Lewis H Titterton Jr | Buy | $3.08 | 10,000 | $30,800 |
| 2025-07-30 | Amit Kumar | Buy | $3.16 | 5,000 | $15,800 |
| 2025-07-18 | Arnold M Baskies | Buy | $3.39 | 5,000 | $16,950 |
| 2025-07-11 | Amit Kumar | Buy | $3.15 | 5,000 | $15,750 |
| 2025-07-11 | Lewis H Titterton Jr | Buy | $3.14 | 10,000 | $31,400 |
| 2025-06-04 | Amit Kumar | Buy | $2.85 | 10,000 | $28,500 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ANIX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ANIX
Institutional investors own 13.9% of Anixa Biosciences's shares and insiders 5.62%. The largest holder is Vanguard Capital Management, LLC with 3.83% of the shares (1.3M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 5 reduced their stake in the latest filings. Short interest is 4.10% of the float, or 3.58 days of average trading volume. The share count rose 219.3% since 2014.
Related: ANIX analyst forecast, ANIX key metrics. See the ANIX stock overview for the latest quote and news.
ANIX ownership FAQ
Who owns the most Anixa Biosciences stock?
The largest shareholders of Anixa Biosciences are Vanguard Capital Management, LLC (3.83%), UBS Group AG (1.68%), Laird Norton Tyee Trust Co (1.66%), Davidson D A & Co (1.55%), Geode Capital Management, LLC (1.03%).
What percentage of Anixa Biosciences is owned by institutions?
Institutions hold 13.9% of Anixa Biosciences's shares outstanding; insiders hold 5.62%.
Which funds own Anixa Biosciences?
The largest fund holders of Anixa Biosciences are Vanguard MStar Total Stk Mkt Idx Invest (2.70%), Fidelity Extended Market Index (0.47%), iShares Micro-Cap ETF (0.29%), Fidelity Total Market Index (0.15%), Fidelity Series Total Market Index (0.13%).
What is Anixa Biosciences's short interest?
1.4M shares of Anixa Biosciences were sold short, 4.10% of the float; at the average daily volume it would take 3.58 days to cover.
Are insiders buying or selling Anixa Biosciences?
Of the latest 7 reported insider transactions in Anixa Biosciences (since June 4, 2025), 7 were purchases and 0 were sales.
How many shares of Anixa Biosciences are outstanding?
Anixa Biosciences has 34.8M shares outstanding, of which 32.8M are in the public float.